Clinical Trial Update: Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the use of Vitamin D for treatment of non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Zurich | Conditions: Non-alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED